Boundless Bio Files 8-K: Material Agreement & Exhibits
Ticker: BOLD · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1782303
| Field | Detail |
|---|---|
| Company | Boundless Bio, INC. (BOLD) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, exhibits
Related Tickers: BOLD
TL;DR
Boundless Bio (BOLD) filed an 8-K for a new material agreement and exhibits. Details TBD.
AI Summary
On April 1, 2025, Boundless Bio, Inc. filed an 8-K report. The filing primarily concerns the entry into a material definitive agreement and the inclusion of financial statements and exhibits. No specific details regarding the agreement or financial figures were provided in the excerpt.
Why It Matters
This filing indicates a significant corporate event for Boundless Bio, Inc., potentially involving a new material agreement that could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — The filing itself is routine, but the 'material definitive agreement' could represent significant undisclosed risk or opportunity.
Key Players & Entities
- Boundless Bio, Inc. (company) — Registrant
- April 1, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Boundless Bio, Inc.?
The provided excerpt does not specify the details of the material definitive agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 1, 2025.
What is the principal executive office address for Boundless Bio, Inc.?
The principal executive office is located at 10955 Alexandra Way, Suite 100, San Diego, California, 92121.
What is the SEC file number for Boundless Bio, Inc.?
The SEC file number for Boundless Bio, Inc. is 001-41989.
What are the main items reported in this 8-K filing?
The filing reports on the 'Entry into a Material Definitive Agreement' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Boundless Bio, Inc. (BOLD).